Deletion of 14-3-3σ Sensitizes Mice to DMBA/TPA-induced Papillomatosis

Oncotarget - United States
doi 10.18632/oncotarget.10478
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

14-3-3 Sigma and P53 Expression in Gastric Cancer and Its Clinical Applications

Disease Markers
BiochemistryMedicineClinical BiochemistryMolecular BiologyGenetics
2010English

High Frequency of Hypermethylation at the 14-3-3 Sigma Locus Leads to Gene Silencing in Breast Cancer

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2000English

Chemopreventive Effects of Cocoa Extract Application Towards Expression of BCL-2 and Mda on Albino Mice Skin Induced by Dmba-Tpa

American Journal of Clinical and Experimental Medicine
2017English

Haploinsufficiency of P18INK4c Sensitizes Mice to Carcinogen-Induced Tumorigenesis

Molecular and Cellular Biology
Cell BiologyMolecular Biology
2003English

LKB1 Deficiency Sensitizes Mice to Carcinogen-Induced Tumorigenesis

Cancer Research
Cancer ResearchOncology
2008English

Targeting 14-3-3 Sensitizes Native and Mutant BCR-ABL to Inhibition With U0126, Rapamycin and BCL-2 Inhibitor GX15-070

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2007English

Negative Regulation of P53-Induced Senescence by N-Wasp Is Crucial for DMBA/TPA-induced Skin Tumor Formation

Cancer Research
Cancer ResearchOncology
2019English

Induction of Activation-Induced Cytidine Deaminase-Targeting Adaptor 14-3-3 Is Mediated by NF- B-Dependent Recruitment of CFP1 to the 5'-CpG-3'-Rich 14-3-3 Promoter and Is Sustained by E2A

Journal of Immunology
AllergyImmunology
2013English

Phosphatidylinositol 3-Kinase Inhibition Broadly Sensitizes Glioblastoma Cells to Death Receptor- And Drug-Induced Apoptosis

Cancer Research
Cancer ResearchOncology
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy